web analytics

Myriad Genetics: Base Building Now … Big Gains in 2009?

December 30, 2008
By

So what’s a potential leader? I could write about some of the (very few) stocks that are hitting new peaks–only 14 stocks hit new peaks on the NYSE and Nasdaq on December 18, for instance–but instead, I’m highlighting a company with huge growth, a big story, and whose stock is in the sixth week of building a good-looking base.

It’s Myriad Genetics (MYGN), which I know has been mentioned in past Cabot Wealth Advisories. To review, the company is the leader in the new field of cancer predisposition testing. It has five tests on the market that tell patients whether their genes make it more likely that they’ll get various types of cancer. During the past few quarters, revenues from these tests have risen at a 50% annual clip, and there’s no sign of that slowing down.

The company also has a pharmaceutical division, but it’s going to spin that off sometime in 2009. That should be a big positive, as the drug development division carries good potential, but also big-time costs. Once the cancer predisposition testing division is on its own, profits are sure to soar.

Not that they’ve been doing badly. Revenues rose 53% to $73.7 million in the third quarter, while earnings soared to 30 cents a share, up from a loss of 18 cents the year-ago quarter. Better yet, analysts expect the bottom line to jump 40% in each of the next two fiscal years. The stock itself actually hit new peaks in early November, despite the market’s weakness, and is now building a new launching pad.

In fact, the past few weeks have successfully taken the stock out of the public’s eye, and while it may need a bit more time to set up, I think it’s primed for a breakout early next year. If the market’s nascent uptrend can persist, I think MYGN can be a big winner.

3 Responses to Myriad Genetics: Base Building Now … Big Gains in 2009?

  1. harbans-lal-gera on August 3, 2009 at 11:49 pm

    Harbans Lal Gera – I know this is off topic but need help with Vista

    Thanks
    Harbans Lal Gera

  2. Alasail on October 14, 2009 at 2:21 am

    I wanna say my opinion. It`s the best site, which I saw before. Thx u a lot

  3. piersi on November 10, 2011 at 8:15 pm

    Our specialty is tractable surgery, as good fettle as non-invasive aesthetic cure-all and cosmetology. The trade mark aga of our services is not limited to: teat enlargement (also using Macrolane), needle mesotherapy treatments, Radiage and many others. Throughout over 12 years, the get of physicians, mortal therapists, physiotherapists and beauticians in our clinic in Warsaw offers something you will not hit upon anywhere else – a encyclopedic service.
    Every mortal physically who goes into our separate approach can guarantee thresholds, pro relief, as positively as turn the clock care.
    We relief patients to pocket a
    determination: surgery, or inoperable. Proposed by us
    without a scalpel compartmentation provides powiekszanie piersi a big kind of dermatology treatments, physiotherapy and cosmetics (eg, coat rejuvenation method Radiage or needle mesotherapy).
    We guaranty anonymity and discretion.
    Each tenacious undergoing surgery can tally
    on the rehabilitation and fresh medical care. All treatments are performed in equipped with the latest equipment, halls and rooms, using plastic tools. Assiduous refuge is our priority.

Leave a Reply

Your email address will not be published. Required fields are marked *

*